Repits Pharma Consulting AB
ActiveKey figures
Key figures
2025Summary: Repits Pharma Consulting AB
What kind of company is it?
Repits Pharma Consulting AB (org. no. 559511-0270) is a limited company (AB). The company was registered in 2024. Registered seat: Trelleborg. Industry according to Statistics Sweden: all other professional, scientific and technical activities n.e.c. (SNI 74990).
How is the company doing financially?
Net sales in financial year 2025 were 553 000 kr. Net profit for 2025 was 396 786 kr (71,8 % of net sales). At the end of financial year 2025, total assets were 679 380 kr and equity 421 786 kr (equity ratio 62,1 %). The annual report for 2025 proposes a dividend of 50 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 50 000 kr.
Summary of annual reports2025
| 2025 | |
|---|---|
| Sales revenue | 553 000 |
| Profit for the reporting year | 396 786 |
| Retained earnings of previous periods | — |
| Total assets | 679 380 |
| Total liabilities | 257 594 |
| Total equity | 421 786 |
| Employees | — |
| Proposed dividend | 50 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.